Cheung KM

No ORCID on file · 2 papers in corpus

2025

AKR1C3 as a therapeutic target to overcome erlotinib resistance in lung adenocarcinoma.

Military Medical Research ·doi:10.1186/s40779-025-00593-4

2023

Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatment.

Journal of cancer research and clinical oncology ·doi:10.1007/s00432-023-04641-1

PurposeCisplatin is the core chemotherapeutic drug used for first-line treatment of advanced non-small cell lung cancer (NSCLC). However, drug resistance is severely hindering its clinical efficacy. This study investigated the circumvention…